NG
HALO icon

Novem Group’s Halozyme HALO Stock Holding History

Novem Group’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$206K Sell
2,632
-523
-17% -$35.7K 0.02% 426
2026
Q1 		$204K Buy
+3,155
New +$222K 0.02% 413
2025
Q4 		– Sell
-2,868
Closed -$210K – 440
2025
Q3 		$210K Buy
+2,868
New +$191K 0.02% 396
2025
Q2 		– Sell
-22,407
Closed -$1.43M – 418
2025
Q1 		$1.43M Buy
22,407
+4,821
+27% +$280K 0.2% 92
2024
Q4 		$841K Buy
+17,586
New +$902K 0.12% 145

Other funds holding HALO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Novem Group's HALO Position: Q2 2026 in Review

Novem Group reduced its Halozyme (HALO) stake by 17% in Q2 2026, selling an estimated $35.7K and leaving 2,632 shares worth $206K. The position accounts for 0.02% of the portfolio, ranked #426.

Novem Group first reported a position in HALO in Q4 2024 and has held it in 5 quarters since. The position peaked at $1.43M in Q1 2025. 671 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • Novem Group held 2,632 shares of Halozyme worth $206K as of Q2 2026.
  • Novem Group sold 523 Halozyme shares in Q2 2026, an estimated $35.7K.
  • Halozyme made up 0.02% of Novem Group's portfolio in Q2 2026, its #426 holding.
  • Novem Group first reported a position in Halozyme in Q4 2024 and has held it in 5 quarters since.
  • Novem Group's Halozyme position peaked at $1.43M in Q1 2025.
  • 671 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Novem Group's 13F filing for Q2 2026, filed 21 Jul 2026.